E-meeting: Developments in the HIV prevention pipeline: PrEP, vaccines and more

#EATG together with AVAC, PrEP in Europe Initiative, and PrEPster, organised a briefing for community educators and advocates on the research and developments along the HIV biomedical prevention pipeline. Meeting content included an overview of the latest PrEP formulations, key clinical trial findings, and advocacy approaches to address regulatory barriers hindering community demand, uptake and access.

This community e-meeting took place on 12 April 2021, 13.00-14.30 CET

The meeting opened with an introduction by Gus Cairns, PrEP in Europe Initiative.
Cindra Feuer (AVAC) introduced The PrEP pipeline Penny Moore (University of the Witwatersrand) briefed participants on bNAbs and vaccines research, and Michael Meullbroek & Ferran Pujol (BCN Checkpoint) highlighted key points for community advocacy. Participants then took part Q&A and discussion session moderated by Will Nutland fromPrEPster. The meeting was then concluded by Gus Cairns, PrEP in Europe Initiative and Sarah North, EATG.

Intro: (0:00)
The PrEP pipeline: beyond daily oral TDF/FTC PrEP by Cindra Feuer: (3:47)
bNAbs and vaccines by Penny Moore, University of the Witwatersrand: (25:00)
Community level advocacy and access by Michael Meullbroek & Ferran Pujol, BCN Checkpoint:(41:51)
Q&A / moderated discussion (59:30)
Meeting wrap-up (1:22:00)

#HIV
#PrEP
#Prevention

Видео E-meeting: Developments in the HIV prevention pipeline: PrEP, vaccines and more канала EATG Media